The Mind on Mushrooms: Psychedelics and the Future of Therapy

Description:What happens when psychedelics move from the underground to the therapist’s office? In this episode, Mike unpacks the real research behind psilocybin, MDMA, and ketamine — the so-called “breakthrough” treatments for depression, PTSD, and trauma.Forget the festival folklore — we’re talking Nature Medicine, JAMA Psychiatry, and NEJM studies that are changing how scientists think about healing the brain. From rewiring rigid thought loops to boosting neuroplasticity, these substances might just teach the mind to loosen up — safely, and under medical supervision.Along the way:The MDMA + therapy trials that helped PTSD patients reclaim their livesPsilocybin’s rapid antidepressant effects and what makes guided sessions so powerfulKetamine and esketamine — how anesthetics became one of psychiatry’s fastest-acting treatmentsWhy microdosing hype doesn’t match placebo-controlled dataAnd why science, not rhetoric, should guide the psychedelic renaissanceBecause the brain deserves more than buzzwords — it deserves evidence (and maybe a sense of humor).Key Studies Mentioned:Mitchell et al., Nature Medicine (2021) — MDMA-assisted therapy for PTSDDavis et al., JAMA Psychiatry (2020) — Psilocybin therapy for major depressionCarhart-Harris et al., PNAS (2014) — Brain network changes under psilocybinLy et al., Cell Reports (2018) — Psychedelics and neuroplasticityBiological Psychiatry (2022) — Ketamine and esketamine for treatment-resistant depressioneLife (2021) — Microdosing and the placebo problemEpisode length: ~9 minutesHost: Mike — Planting Thoughts / Brain Blossoms🎧 Listen, learn, and keep your skepticism stylish.